Delagil® [Chloroquine]
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
The antiprotozoal agent also has an immunosuppressive and anti-inflammatory effect. Delagil causes the death of asexual erythrocyte forms of all types of plasmodia. It has a gametocidal effect, with the exception of Plasmodium falciparum (exhibits anti-gametocidal action).
Indications
Malaria (prevention and treatment of all types), extraintestinal amebiasis, amebic liver abscess, systemic lupus erythematosus (SLE) (chronic and subacute forms), rheumatoid arthritis, scleroderma, photodermatosis.
Composition
1 tablet contains chloroquine 250 mg
No customer reviews for the moment.
Dosage and Administration
Delagil is taken orally, after meals.
In the treatment of malaria prescribed 2-2.75 g per course of treatment: 1 g / first day, after 11-12 hours 0.5 g, on the second and third day - 0.5-0.75 g at one time. The maximum dosage for adults is 1.5 g at a time. Children 6-10 years prescribed 0.25 g in the first day, then 0.125 g in the second and third days of treatment. Children 10-15 years old - 0.5 g / first day, then 0.25 g each on the second and third day.
Prevention of malaria infection: 0.5 g twice a week, then 0.5 g once a week. In the case of rheumatoid arthritis, Delagil is taken at a rate of 0.5 g / day for 2 doses for 6–8 days. Then daily 0.25 g for 12 months.
Adverse reactions
- Of the nervous system: dizziness, psychomotor agitation, headache, insomnia, psychosis, neuropathy, seizures.
- From the side of the musculoskeletal system: myopathy.
- On the part of sensitive analyzers: hearing loss, tinnitus, impaired visual perception, corneal clouding, retinopathy, accommodation disturbance, reversible keratopathy.
- On the part of the digestive system: nausea, vomiting, diarrhea, anorexia, abdominal pain of a spastic nature, weight loss, hepatotoxicity.
- From the side of vascular system: development of arterial hypotension, cardiomyopathy is possible.
- Skin manifestations: dermatitis, pruritus, rash, photosensitivity, impaired skin pigmentation, hair loss.
Contraindications
Renal and hepatic failure, severe cardiac arrhythmias, oppression of blood formation in the bone marrow, porphyrinuria, neutropenia, hypersensitivity to the constituent components of the drug, children under 6 years of age.
Drug interactions
The combined use of other antimalarial drugs enhances the action of Delagil. Can not be taken in conjunction with gold medications, cytostatics, penicillamine, levamisole, because This may increase the side effects of the drug. When used together with MAO inhibitors, the toxic effect is enhanced. With long-term use of Delagil together with cardiac glycosides may develop glycoside intoxication. Ethanol enhances the toxic effect of Delagil on the liver.
Overdosage
Overdose of this drug causes loss of consciousness, vomiting, respiratory depression, seizures, collapse. In case of overdose, it is necessary to flush the stomach, take the adsorbents inside. In severe cases of poisoning, plasmapheresis and peritoneal dialysis are possible.
- Brand name: Delagil
- Active ingredient: Chloroquine
- Dosage form: pills
- Manufacturer: Meda Pharma GmbH & Co. KG
- Country of Origin: Switzerland
Studies and clinical trials of Chloroquine (Click to expand)
- Effect of chloroquine-induced myopathy on rat soleus muscle sarcoplasm and expression of clathrin
- Familial interstitial lung disease in children: Response to chloroquine treatment in one sibling with desquamative interstitial pneumonitis
- No effect of chloroquine on theophylline pharmacokinetics in the rat
- Polyamine metabolism in various tissues during pathogenesis of chloroquine-susceptible and resistant malaria
- Preparation of 198Au(I)-labelled gold-chloroquine complex [198Au(PPh3)(CQ)]PF6 as a potential antimalarial agent
- Diagnosis of a case of acute chloroquine poisoning using 1H NMR spectroscopy: characterisation of drug metabolites in urine
- Synthesis and optical properties of the chloroquine enantiomers and their complexes with ferriprotoporphyrin IX in aqueous solution
- Studies on the role of proteases in the white-rot fungus Trametes versicolor: Effect of PMSF and chloroquine on ligninolytic enzymes activity
- Enhancement of the radiation response of cultured tumor cells by chloroquine
- In vitro activity of chloroquine and quinine in combination with desferrioxamine against Plasmodium falciparum
- Soluble Synthetic Analogues of Malaria Pigment: Structure of Mesohematin Anhydride and its Interaction with Chloroquine in Solution
- Titelbild: Soluble Synthetic Analogues of Malaria Pigment: Structure of Mesohematin Anhydride and its Interaction with Chloroquine in Solution (Angew. Chem. 27/2011)
- Soluble Synthetic Analogues of Malaria Pigment: Structure of Mesohematin Anhydride and its Interaction with Chloroquine in Solution
- Cover Picture: Soluble Synthetic Analogues of Malaria Pigment: Structure of Mesohematin Anhydride and its Interaction with Chloroquine in Solution (Angew. Chem. Int. Ed. 27/2011)
- From Chloroquine to Antineoplastic Drugs? The Story of Antibacterial Quinolones
- A controlled study of chloroquine as an antirheumatic agent
- Chloroquine and hydroxychloroyuine therapy in rheumatoid arthritis
- A double-blind comparison of the anti-rheumatic properties of amopyroquin-HCl (Propoquin) and chloroquine-diphosphate
- Effect of chloroquine on the sulfhydryl group and the denaturation of bovine serum albumin
- Diplopia and loss of accommodation due to chloroquine
- An appraisal of chloroquine
- Prevention by chloroquine of hexosamine cartilage depletion by e-prostaglandins
- Chloroquine inhibits the production of a mononuclear cell factor by inhibition of lectin binding
- A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis